New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of ...

As the demand for holistic and preventative healthcare grows, occupational therapists (OTs) are proving to be indispensable ...

If it doesn’t improve, a doctor will examine the foot and create a treatment plan that may include foot pads, physical therapy, and other interventions. Sesamoiditis is a type of bone ...

Nucula’s new indication is as an add-on therapy for patients with COPD who also have an elevated blood eosinophil count.

Triple therapy for COPD is more likely to offer cardiopulmonary benefits vs dual therapy, as indicated by NNT estimates for key cardiac outcomes.

M. Bradley Drummond, MD, MHS, professor of medicine, University of North Carolina at Chapel Hill, shares promising results of ensifentrine in helping patients with insufficient chronic obstructive ...

Mepolizumab has had a bumpy road to arriving at its indication in COPD. An FDA advisory committee in 2018 declined to ...

The FDA granted approval to mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

The FDA has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain COPD patients whose disease isn't ...

Chiesi is hoping real world evidence will show its latest COPD triple therapy can help cut hospital admissions for the disease. Trimbow (beclometasone+formoterol+glycopyrronium) combines an ...

“I tore my meniscus in my knee, and I didn’t even bother with physical therapy or anything. I just came right to Siobhan,” she said. After six weeks of treatment and some basic rehab ...

GSK plc GSK announced that the FDA has approved its blockbuster respiratory drug, Nucala (mepolizumab), for a fifth ...